Inhibitors of Mre11, Rad50 And/or Nbs1
The invention provides, inter alia, compositions comprising an inhibitor of MRE11, RAD50 and/or NBSl and methods of using such inhibitor for modulating the cellular response to DNA damage, arresting the cell cycle, and/or treatment of cancer. The inhibitor is, e.g., a compound of formula I:
Attached files:Patents:WO 2,010,075,372
Inventor(s):
GAUTIER JEAN [US]; KOPELOVICH LEVY [US]
Type of Offer:
Licensing
« More Pharmaceutical Patents